Compare STIM & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STIM | OCCI |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.5M | 120.2M |
| IPO Year | 2018 | N/A |
| Metric | STIM | OCCI |
|---|---|---|
| Price | $1.44 | $2.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 418.8K |
| Earning Date | 03-17-2026 | 12-11-2023 |
| Dividend Yield | N/A | ★ 24.32% |
| EPS Growth | ★ 57.25 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $52,776,000.00 | N/A |
| Revenue This Year | $11.51 | N/A |
| Revenue Next Year | $11.63 | $10.19 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.80 | $2.76 |
| 52 Week High | $5.05 | $6.82 |
| Indicator | STIM | OCCI |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 33.65 |
| Support Level | $1.22 | $2.83 |
| Resistance Level | $1.46 | $3.07 |
| Average True Range (ATR) | 0.16 | 0.12 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 85.81 | 39.29 |
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.